(Q37770113)

22 August 2017

1 reference

title

Atherosclerosis, diabetes and lipoproteins (English)

1 reference

22 August 2017

1 reference

1 reference

Gerald H Tomkin

1

1 reference

22 August 2017

publication date

1 July 2010

1 reference

Expert Review of Cardiovascular Therapy

22 August 2017

published in

1 reference

22 August 2017

volume

8

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

1015-1029

1 reference

Childhood obesity, other cardiovascular risk factors, and premature death

22 August 2017

cites work

1 reference

21 January 2018

1 reference

Dr Black's favourite disease

21 January 2018

1 reference

Atherosclerosis is an inflammatory disease

21 January 2018

1 reference

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force

21 January 2018

1 reference

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

21 January 2018

1 reference

Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes

21 January 2018

1 reference

Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells.

21 January 2018

1 reference

Generation of C-reactive protein and complement components in atherosclerotic plaques

21 January 2018

1 reference

Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein

21 January 2018

1 reference

Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects

21 January 2018

1 reference

C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling

21 January 2018

1 reference

C-reactive protein inhibits endothelium-dependent nitric oxide-mediated dilation of retinal arterioles via enhanced superoxide production

21 January 2018

1 reference

C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase

21 January 2018

1 reference

C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction.

21 January 2018

1 reference

Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats

21 January 2018

1 reference

C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells

21 January 2018

1 reference

Modification of PI3K- and MAPK-dependent chemotaxis in aortic vascular smooth muscle cells by protein kinase CbetaII.

21 January 2018

1 reference

Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways

21 January 2018

1 reference

Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study

21 January 2018

1 reference

C-reactive protein induces apoptosis in human coronary vascular smooth muscle cells

21 January 2018

1 reference

Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?

21 January 2018

1 reference

Does elevated C-reactive protein cause human atherothrombosis? Novel insights from genetics, intervention trials, and elsewhere

21 January 2018

1 reference

The evolving role of C-reactive protein in atherothrombosis

21 January 2018

1 reference

Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions

21 January 2018

1 reference

The pathology of atherosclerosis: plaque development and plaque responses to medical treatment

21 January 2018

1 reference

The process of atherogenesis--cellular and molecular interaction: from experimental animal models to humans

21 January 2018

1 reference

Stents versus coronary-artery bypass grafting for left main coronary artery disease.

21 January 2018

1 reference

Acute coronary syndromes without ST-segment elevation--what is the role of early intervention?

21 January 2018

1 reference

Nitric oxide: a unique endogenous signaling molecule in vascular biology

21 January 2018

1 reference

Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases

21 January 2018

1 reference

The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans

21 January 2018

1 reference

The flame that lights the fire: oxidative stress, inflammation, and renal damage in angiotensin II-induced hypertension.

21 January 2018

1 reference

Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis

21 January 2018

1 reference

The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression

21 January 2018

1 reference

The macrophage at the crossroads of insulin resistance and atherosclerosis

21 January 2018

1 reference

Macrophage death and defective inflammation resolution in atherosclerosis

21 January 2018

1 reference

Innate and acquired immunity in atherogenesis

21 January 2018

1 reference

Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells

21 January 2018

1 reference

Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis

21 January 2018

1 reference

Immunomodulation of atherosclerosis with a vaccine

21 January 2018

1 reference

Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences

21 January 2018

1 reference

Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes

21 January 2018

1 reference

Toll like receptor 4 in atherosclerosis and plaque destabilization

21 January 2018

1 reference

Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease

21 January 2018

1 reference

Autoantibodies against modified low-density lipoproteins in coronary artery disease

21 January 2018

1 reference

Immunoglobulin M Type of Autoantibodies to Oxidized Low-Density Lipoprotein Has an Inverse Relation to Carotid Artery Atherosclerosis

21 January 2018

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women

21 January 2018

1 reference

FoxO1 integrates insulin signaling to VLDL production

21 January 2018

1 reference

Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation

21 January 2018

1 reference

Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study

21 January 2018

1 reference

The metabolic syndrome: prevalence, CHD risk, and treatment

21 January 2018

1 reference

Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin

21 January 2018

1 reference

A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein-cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism--The Hoorn Study

21 January 2018

1 reference

Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12 000 men and women from The Copenhagen City Heart Study

21 January 2018

1 reference

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

Combination therapy of statins and fibrates in the management of cardiovascular risk

21 January 2018

1 reference

Bezafibrate in men with lower extremity arterial disease: randomised controlled trial

21 January 2018

1 reference

Determination of apolipoprotein B-48 in serum by a sandwich ELISA.

21 January 2018

1 reference

Atherogenesis: a postprandial phenomenon

21 January 2018

1 reference

Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study

21 January 2018

1 reference

Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits.

21 January 2018

1 reference

Identification of lipoproteins of intestinal origin in human atherosclerotic plaque

21 January 2018

1 reference

Detection of apolipoproteins B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases

21 January 2018

1 reference

Are we ready for a prospective study to investigate the role of chylomicrons in cardiovascular disease?

21 January 2018

1 reference

Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes.

21 January 2018

1 reference

Low synthesis and high absorption of cholesterol characterize type 1 diabetes

21 January 2018

1 reference

Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption

21 January 2018

1 reference

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

21 January 2018

1 reference

Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux

21 January 2018

1 reference

Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD.

21 January 2018

1 reference

The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease

21 January 2018

1 reference

In-vitro characterization of the six clustered variants of NPC1L1 observed in cholesterol low absorbers

21 January 2018

1 reference

Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment

21 January 2018

1 reference

Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly

21 January 2018

1 reference

The different effect of pioglitazone as compared to insulin on expression of hepatic and intestinal genes regulating post-prandial lipoproteins in diabetes

21 January 2018

1 reference

Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein

21 January 2018

1 reference

Ezetimibe inhibits the incorporation of dietary oxidized cholesterol into lipoproteins.

21 January 2018

1 reference

Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters

21 January 2018

1 reference

The mechanism of ABCG5/ABCG8 in biliary cholesterol secretion in mice.

21 January 2018

1 reference

ABCG5 and ABCG8 Are Obligate Heterodimers for Protein Trafficking and Biliary Cholesterol Excretion

21 January 2018

1 reference

Quantifying anomalous intestinal sterol uptake, lymphatic transport, and biliary secretion in Abcg8(-/-) mice.

21 January 2018

1 reference

Single nucleotide polymorphisms in ABCG5 and ABCG8 are associated with changes in cholesterol metabolism during weight loss

21 January 2018

1 reference

Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity

21 January 2018

1 reference

Down-regulation of hepatic and intestinal Abcg5 and Abcg8 expression associated with altered sterol fluxes in rats with streptozotocin-induced diabetes

21 January 2018

1 reference

Genes that affect cholesterol synthesis, cholesterol absorption, and chylomicron assembly: the relationship between the liver and intestine in control and streptozotosin diabetic rats.

21 January 2018

1 reference

Microsomal triglyceride transfer protein polymorphisms and lipoprotein levels in type 2 diabetes.

21 January 2018

1 reference

The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease

21 January 2018

1 reference

JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs

21 January 2018

1 reference

Microsomal triglyceride transfer protein gene polymorphism strongly influences circulating malondialdehyde-modified low-density lipoprotein.

21 January 2018

1 reference

Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes.

21 January 2018

1 reference

Lipid and lipoprotein dysregulation in insulin resistant states

21 January 2018

1 reference

Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes

21 January 2018

1 reference

Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster

21 January 2018

1 reference

Intestinal microsomal triglyceride transfer protein in type 2 diabetic and non-diabetic subjects: the relationship to triglyceride-rich postprandial lipoprotein composition

21 January 2018

1 reference

An intrinsic gut leptin-melanocortin pathway modulates intestinal microsomal triglyceride transfer protein and lipid absorption

21 January 2018

1 reference

Native LDL-cholesterol mediated monocyte adhesion molecule overexpression is blocked by simvastatin.

21 January 2018

1 reference

Small dense LDL and VLDL predict common carotid artery IMT and elicit an inflammatory response in peripheral blood mononuclear and endothelial cells

21 January 2018

1 reference

Activation of peripheral blood CD14+ monocytes occurs in diabetes

21 January 2018

1 reference

Low density lipoprotein can cause death of islet beta-cells by its cellular uptake and oxidative modification

21 January 2018

1 reference

Diabetic dyslipidaemia: from basic research to clinical practice.

21 January 2018

1 reference

The clinical relevance of LDL size and subclasses modulation in patients with type-2 diabetes

21 January 2018

1 reference

Low density lipoprotein non-esterified fatty acids and lipoprotein lipase in diabetes.

21 January 2018

1 reference

Oxidative modification of triacylglycerol-rich lipoproteins

21 January 2018

1 reference

Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins

21 January 2018

1 reference

Coronary artery calcium and cardiovascular risk in diabetes

21 January 2018

1 reference

Importance of small intestine in diabetic hypercholesterolemia

21 January 2018

1 reference

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes.

21 January 2018

1 reference

Tumor necrosis factor-increased hepatic very-low-density lipoprotein production and increased serum triglyceride levels in diabetic rats

21 January 2018

1 reference

Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related ki

21 January 2018

1 reference

Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins.

21 January 2018

1 reference

Defective chylomicron synthesis as a cause of delayed particle clearance in diabetes?

21 January 2018

1 reference

The relationship between cholesterol absorption and intestinal cholesterol synthesis in the diabetic rat model

21 January 2018

1 reference

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

21 January 2018

1 reference

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

21 January 2018

1 reference

Triglycerides and the Risk of Coronary Heart Disease

21 January 2018

1 reference

Postprandial lipoproteins and progression of coronary atherosclerosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERC.10.45

1 reference

22 August 2017

1 reference